Launch of Seegene’s STARlet-AIOS: All-in-One System Fulfills Critical Need for Fully Automated, High-Throughput Real-Time PCR Testing
A true walk away 'sample to answer' molecular diagnostic system designed for high throughput testing, offering a time-efficient and seamless workflow for clinical laboratories Utilizes Seegene's patented, cutting-edge high multiplex real-time PCR technologies to provide 'Real' Ct values of individual pathogens in a single channel. Utilizes Seegene's broad...
Adagene Establishes Collaboration for Clinical Trial of ADG106 in Combination with Nivolumab in Patients with Non-Small Cell Lung Cancer in Singapore
- Phase 1b/2 trial to be conducted at the National University Cancer Institute, Singapore and the National Cancer Centre Singapore, in Collaboration with the Singapore Translational Cancer Consortium - - ADG106 now being evaluated in combinations with three leading anti-PD-1 therapies - SAN DIEGO, SUZHOU, China, and SINGAPORE, Oct. 27, 2021 /PRNewswire/ -- Adagene Inc. ("Adagene") (Nasdaq: ADAG), the...
Frontier Biotechnologies’ Long-acting Injectable (Aikening(R)), in a Two Drug Regimen, Proves Safe and Effective for Critically Ill Hospitalized AIDS Patients
LONDON, Oct. 27, 2021 /PRNewswire/ -- Frontier Biotechnologies today shared real-world evidence of Albuvirtide (ABT)-based two drug regimen's safety and efficacy for hospitalized AIDS patients at the European AIDS Clinical Society (EACS) Conference. Observations from a single-center, retrospective cohort study of 160 critically ill hospitalized patients with high viral load showed rapid...
Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom
Filing marks first protein-based COVID-19 vaccine submitted to MHRA for authorization All modules required for regulatory review, including CMC data, are now complete Submission based on Phase 3 data from ~45K patients demonstrating high efficacy and well-tolerated safety, including against variants Submissions to additional global regulatory authorities...
European Wellness Collaborates with Heidelberg University Germany to Conduct Efficacy Studies of Peptides and Cell Therapy Research
FRANKFURT, Germany, Oct. 27, 2021 /PRNewswire/ – European Wellness Academy (EWA), the educational arm of European Wellness Biomedical Group (EWG), has signed an agreement to carry out joint scientific research on the efficacy of peptides, cell therapy, exosomes and cell reprogramming for rejuvenation in premature murine aging models. EWA was represented by...
Waterdrop Inc offers Huiminbao services to raise insurance coverage for China’s underserved consumer population
BEIJING, Oct. 27, 2021 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or "the Company"), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, has taken a leading position in the government-backed health insurance product (known as "Huiminbao") market, one of the fastest growing government-backed commercial health insurance products in the Chinese insurance industry...
GSTHR: “Moral imperative” for WHO to adopt harm reduction for tobacco
LONDON, Oct. 27, 2021 /PRNewswire/ -- While global leaders and media focus on UN COP26, the climate summit starting this Sunday, 182 government delegations are preparing for another COP meeting. Yet the ninth session of the COP (COP9) to the WHO Framework Convention on Tobacco Control (FCTC) from 8 - 13 November has received little attention and will be...
Launch of #SGUnited COVID-19 Assistance Telemedicine Initiative by UNO Tech
SINGAPORE, Oct. 27, 2021 /PRNewswire/ -- Singapore has seen a sharp increase in daily COVID-19 cases since September, reaching an approximate average of 3,000 daily cases. Primary Care avenues such as General Practitioners and Telemedicine service providers are stretched thin. UNO Technologies launches COVID-19 Assistance Telemedicine Initiative UNO Technologies (https://www.unotech.io/uno-docket-covid19-assistance/) has mobilized its resources to modify its...
HT Supreme® Drug Eluting Stent performs equivalent to best-in-class in the PIONEER III publication
TIANJIN, China, Oct. 27, 2021 /PRNewswire/ -- SINOMED, a leading international medical device company, announced that the clinical trial results for its HT Supreme® Drug-Eluting Stent (DES) System has been published in Circulation. The article described results from the PIONEER III trial where investigators demonstrated equivalence in safety and effectiveness between the...
Abcam completes $340m strategic acquisition and expands kit capacity and capability
- Completing $340m strategic acquisition of BioVision - Expanding facilities in Eugene, further growing kits and assays portfolio - Supporting the growing demand of the sector and accelerating execution of strategic plan CAMBRIDGE, England, Oct. 27, 2021 /PRNewswire/ -- Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools, today...
